Quality assured
Confidentiality assured
Custom research services
The global pharmaceutical polymers market, which recorded a whooping valuation of US$ 20.44 billion in the year 2022, is projected to experience substantial growth in the forthcoming years.
Market Overview
The global medical polymers market is experiencing substantial growth and is poised to continue this trend over the next decade. Valued at USD 20.44 billion in 2022, the market size is projected to reach USD 38.3 billion by 2030, propelled by a robust CAGR of 8.16% during the forecast period. Medical polymers, fundamental to the healthcare sector, are witnessing increasing demand, particularly due to their utility in producing medical implants, driven by chronic illnesses and an aging population.
The market growth is also spurred by the expanding pharmaceutical device industry, an aging global population necessitating increased medical treatments, and evolving trends toward home healthcare.
Furthermore, the heightened interest in employing therapeutic polymers to produce clinical devices and equipment is expected to fuel market expansion. However, fluctuating raw material prices, stringent regulations, and extended regulatory clearance procedures are potential obstacles the industry must navigate. Despite these challenges, significant opportunities lie in advancing R&D to innovate patient-specific implants, improved polymers, and 3D-printed devices.
In 2020, fibers and resins, including PVC and PP, accounted for 74.36% of the total market share, underlining their broad-ranging applications in the fabrication of medical devices and equipment. With the rising demand for new, advanced medical equipment and the growing home healthcare sector, the penetration of these medical polymers is set to increase markedly in the coming years.
Key Report Findings
Market Drivers
Increased Demand for Medical Implants
The growing prevalence of chronic diseases and an aging global population have led to a substantial increase in the demand for medical implants. This demand is a significant driver for the medical/ pharmaceutical polymer market, as these materials are integral to producing these implants.
Expanding Pharmaceutical Device Industry
The pharmaceutical device sector's expansion is contributing to the increased demand for medical/ pharmaceutical polymers. As the sector continues to grow rapidly, the demand for materials such as medical-grade polymers that produce these devices is expected to rise in tandem.
Aging Population and Increased Medical Treatments
An aging global population necessitates more medical treatments and interventions. This increased demand for medical treatments fuels the growth of the medical/ pharmaceutical polymer market, as these materials are key to producing a wide range of medical devices and equipment.
Growth of Home Healthcare
The growing trend toward home healthcare has led to an increased demand for home-use medical equipment and devices, which often rely on medical-grade polymers for production. This shift towards home healthcare is expected to continue, further driving the demand for medical polymers.
Rising Interest in Therapeutic Polymers
There is an increased interest in using therapeutic polymers to assemble clinical devices and equipment. The growth in this interest is due to the polymers' potential to enhance the functionality and performance of these devices, driving further growth in the medical polymers market.
Investments in Clinical Innovation
Legislators in numerous countries are funding clinical innovation research and development (R&D) projects to strengthen the foundation of medical services. These investments facilitate the developing and commercializing of novel medical/ pharmaceutical polymers, thus boosting market growth.
Market Opportunities
Expansion of Biodegradable Materials in Medical Implants Production
The growing use of biodegradable materials in the production of medical implants presents a significant opportunity for the medical polymer market. Environmental concerns and stringent regulatory guidelines for polymers used in the medical industry have resulted in an increased demand for biodegradable medical implants, which can serve as cost-effective and efficient alternatives to traditional implant materials.
Increasing Relevance of Medical Elastomer
The growing importance of medical elastomers like styrene block copolymers and rubber latex in healthcare creates new market opportunities. These materials offer excellent elasticity and durability, making them ideal for use in a wide range of medical applications, from gloves to tubing to catheters.
Rising Use of Fibers and Resins in Medical Procedures
The increase in the use of resins and fibers in medical procedures such as spinal implants and hip replacements offers another opportunity for the medical polymers market. These materials offer improved biocompatibility and are less costly compared to traditional materials, making them an attractive choice for these procedures.
Advanced Biopolymers
Market players are focusing on the development of new and advanced biopolymers. The introduction of these innovative materials is expected to increase the use of clinical polymers in a variety of applications, further expanding the market.
Patient-Specific Implants and 3D Printing
With technological advancements, there's a growing demand for patient-specific implants and 3D-printed medical devices. The production of these customized solutions often relies on medical polymers, presenting a significant opportunity for market growth.
Market Challenges
Fluctuating Raw Material Prices
A major challenge facing the medical polymer market is the unpredictable trend of raw material prices, largely driven by volatile energy costs. These price fluctuations can increase production costs, impacting the profitability of market participants and potentially restraining market growth.
Stringent Regulatory Policies
Stringent regulations imposed by governing bodies such as the United States Food and Drug Administration (FDA) and the European Union (EU) present another hurdle for the medical polymer market. These strict rules, particularly those governing the introduction of new products, can slow down the rate of market innovation and growth.
Lengthy Regulatory Clearance Process
The often lengthy and complex process of obtaining regulatory clearances for new products can impede market growth. This prolonged procedure can delay the introduction of new and innovative medical polymers into the market, limiting the potential for market expansion.
Limited Awareness of Modern Medical Techniques
A lack of understanding or awareness of modern medical techniques and technologies among some sections of the global population can adversely affect the market's growth. This limited awareness can reduce the demand for advanced medical devices and implants that rely on medical polymers.
Waste Management
Managing and disposing of waste produced during the manufacture and use of medical polymers is a significant challenge. It raises environmental concerns and may impose additional costs on manufacturers. These challenges need to be addressed effectively to sustain the growth of polymers.
Regional Coverage
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Company Recent Development
Major players operating in the pharmaceutical polymers market include:
On November 17th, 2021, Evonik Industries AG introduced a new kind of RESOMER Print Powder polymer. This was done to facilitate the 3D printing of personalized, implantable medical devices. This innovation makes it possible to use selective laser sintering (SLS) in the 3D printing process and is expected to broaden the application of medical polymers in the production of patient-specific implants.
Eastman Chemical Corporation, on the other hand, announced the debut of a new family of medical-grade polymers at the MedTec Europe trade event in Stuttgart, Germany, on July 1st, 2021. Known as Eastman Tritan copolyester medical grades, these transparent polymers offer a combination of molding, design, as well as end-product attributes, making them a highly viable choice for medical devices.
Considering the volatility of business today, traditional approaches to strategizing a game plan can be unfruitful if not detrimental. True ambiguity is no way to determine a forecast. A myriad of predetermined factors must be accounted for such as the degree of risk involved, the magnitude of circumstances, as well as conditions or consequences that are not known or unpredictable. To circumvent binary views that cast uncertainty, the application of market research intelligence to strategically posture, move, and enable actionable outcomes is necessary.
View Methodology
Quality assured
Confidentiality assured
Custom research services
